TGA Sciences

Medford, United States Founded: 1998 • Age: 28 yrs Acquired By Absorption
CRO that specializes in the development and validation of immunoassay systems and preclinical studies

About TGA Sciences

TGA Sciences is a Healthcare company based in Medford (United States) founded in 1998, and was acquired by Absorption in November 2017. CRO that specializes in the development and validation of immunoassay systems and preclinical studies. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its competitors include BioAgilytix, Advion and Evans Analytical Group; 1 of its 3 listed competitors has raised funding.

Company details

TGA Sciences is a contract research organization (CRO) providing the Pharmaceutical, Biotechnology and Academic communities a comprehensive range of laboratory services in support of basic research and development as well as for clinical studies. They offer clients a package of customized testing systems and facilities for pre-clinical studies (on mouse, rats and guinea pigs) and also offer Analytical, immunochemistry, bioassay and other lab-based RD services throughout the clinical trial phases. It is AAALAC accredited and USDA registered, and maintains an internal Institutional Animal Care and Use Committee (IACUC) in accordance with USDA and HHS regulations and guidelines. The company is FDAEMA registered and inspected, and provides GLP and cGMP regulatory-compliant services for FDAEMA-level applications and submissions when requested by the client. They offer dedicated QAQC personnel to ensure compliance to the required guidelines. TGA Sciences specializes in the development and validation of immunoassay systems for the detection of target molecules, antibody responses, and quantification. They serve clients both in the U.S. and internationally.

  • Headquarters Medford, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website tgasciences.com
  • Social LinkedIn X Facebook
  • Acquired by Absorption (Nov 2017)
Key Metrics

Investors in TGA Sciences

TGA Sciences has secured backing from 1 investor. Prominent investors backing the company include Absorption.

All
InvestorDescriptionFounded YearDomainLocation
Integrated preclinical research services for drugs and devices are provided.
1996absorption.comExton, United States
Premium access

Investor details for TGA Sciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of TGA Sciences

2 dated milestones of TGA Sciences across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded TGA Sciences is founded.
  2. Exit Acquired by Absorption.

Competitors of TGA Sciences

TGA Sciences has 3 listed competitors in our database, 1 of them funded. They include BioAgilytix, Advion and Evans Analytical Group.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bioagilytix.com2008Durham, United States446
Large-molecule bioanalysis is provided for biologics and biosimilars development.
advion.com1993Ithaca, United States$45.64M54
Microfluidics and mass spectrometry products are provided for clinical research.
eag.com1978San Diego, United States601
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
Premium access

Detailed competitors of TGA Sciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as TGA Sciences (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Tga Sciences

Premium access

Complete news archive for TGA Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about TGA Sciences

TGA Sciences was founded in 1998.

TGA Sciences is headquartered in Medford, United States. It is registered at Medford, Oregon, United States.

TGA Sciences is a contract research organization (CRO) providing the Pharmaceutical, Biotechnology and Academic communities a comprehensive range of laboratory services in support of basic research and development as well as for clinical studies. They offer clients a package of customized testing systems and facilities for pre-clinical studies (on mouse, rats and guinea pigs) and also offer Analytical, immunochemistry, bioassay and other lab-based RD services throughout the clinical trial phases. It is AAALAC accredited and USDA registered, and maintains an internal Institutional Animal Care and Use Committee (IACUC) in accordance with USDA and HHS regulations and guidelines. The company is FDAEMA registered and inspected, and provides GLP and cGMP regulatory-compliant services for FDAEMA-level applications and submissions when requested by the client. They offer dedicated QAQC personnel to ensure compliance to the required guidelines. TGA Sciences specializes in the development and validation of immunoassay systems for the detection of target molecules, antibody responses, and quantification. They serve clients both in the U.S. and internationally.

TGA Sciences's top competitors include BioAgilytix, Advion and Evans Analytical Group.

TGA Sciences has 1 investor. Key investors include Absorption.

Yes. TGA Sciences was acquired by Absorption in November 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available